Virginie Prendki Selected Research

Pneumonia (Pneumonitis)

11/2022	Atypical Pathogens in Adult Community-Acquired Pneumonia and Implications for Empiric Antibiotic Treatment: A Narrative Review.
9/2022	Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysis.
5/2022	Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia.
1/2022	Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia.
1/2022	Association Between Early Antibiotic Therapy and In-Hospital Mortality Among Older Patients With SARS-CoV-2 Pneumonia.
1/2022	LOw-dose CT Or Lung UltraSonography versus standard of care based-strategies for the diagnosis of pneumonia in the elderly: protocol for a multicentre randomised controlled trial (OCTOPLUS).
12/2021	Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia.
1/2020	Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study.
4/2019	Rational Use of CT-Scan for the Diagnosis of Pneumonia: Comparative Accuracy of Different Strategies.
1/2019	Computed tomography scan contribution to the diagnosis of community-acquired pneumonia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginie Prendki Research Topics

Disease

13	Pneumonia (Pneumonitis) 11/2022 - 09/2017
9	Infections 04/2024 - 03/2011
8	COVID-19 12/2023 - 11/2020
2	Herpes Zoster 04/2024 - 03/2024
2	Abscess 01/2020 - 01/2013
2	Malaria 09/2016 - 01/2014
1	Human Influenza (Influenza) 04/2024
1	Neuralgia (Stump Neuralgia) 03/2024
1	Viremia 03/2024
1	Fever (Fevers) 03/2023
1	Sepsis (Septicemia) 01/2023
1	Inflammation (Inflammations) 09/2022
1	Frailty 06/2022
1	Critical Illness (Critically Ill) 02/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Dementia (Dementias) 12/2021
1	Periodontitis 04/2021
1	Cognitive Dysfunction 12/2020
1	Headache (Headaches) 11/2020
1	Respiratory Sounds (Crackle) 11/2020
1	Heart Failure 11/2020
1	Peripheral Arterial Disease 11/2020
1	Rhabdomyolysis 01/2020
1	Hypercholesterolemia 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Necrosis 01/2020
1	Muscle Weakness 01/2020
1	Bacteremia 01/2020
1	Cough 04/2019
1	Autoimmune Diseases (Autoimmune Disease) 10/2018
1	Pleural Effusion (Pleural Effusions) 10/2018
1	Hypoxia (Hypoxemia) 09/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2016
1	Latent Tuberculosis 05/2015
1	Lymphopenia (Lymphocytopenia) 11/2014
1	Acute malaria 01/2014
1	Diarrhea 11/2013
1	Colitis 11/2013
1	Neurofibromatoses (Neurofibromatosis) 05/2011
1	Hypophosphatemia 05/2011

Drug/Important Bio-Agent (IBA)

12	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 11/2013
6	C-Reactive ProteinIBA 03/2023 - 04/2019
3	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2020
2	Oxygen (Dioxygen)IBA 03/2023 - 11/2020
2	remdesivirIBA 01/2023 - 02/2022
2	NeopterinIBA 09/2022 - 01/2020
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 09/2022 - 01/2020
2	AntibodiesIBA 07/2022 - 01/2022
2	Ritonavir (Norvir)FDA Link 02/2022 - 12/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2022 - 12/2020
2	Lopinavir FDA Link 02/2022 - 12/2020
2	AutoantibodiesIBA 10/2018 - 01/2014
2	Antinuclear AntibodiesIBA 10/2018 - 01/2014
1	VaccinesIBA 04/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	CreatinineIBA 03/2023
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2022
1	InterleukinsIBA 09/2022
1	Immunoglobulin M (IgM)IBA 09/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022
1	Peroxidase (Myeloperoxidase)IBA 09/2022
1	Phosphorylcholine (Phosphocholine)IBA 09/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2022
1	SteroidsIBA 02/2022
1	tocilizumab (atlizumab)FDA Link 02/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2021
1	pro-brain natriuretic peptide (1-76)IBA 12/2021
1	ProcalcitoninIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 04/2019
1	hemoglobin AAIBA 09/2016
1	Inosine Triphosphate (ITP)IBA 03/2016
1	Vincristine (Oncovin)FDA LinkGeneric 03/2016
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	AutoantigensIBA 01/2014
1	Metronidazole (Metric)FDA LinkGeneric 11/2013
1	Vancomycin FDA LinkGeneric 11/2013
1	Immunologic Factors (Immunomodulators)IBA 01/2013
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 05/2011
1	Tenofovir (Viread)FDA Link 05/2011
1	Phosphates (Orthophosphate)IBA 05/2011

Therapy/Procedure

12	Therapeutics 12/2023 - 05/2011
2	Critical Care (Surgical Intensive Care) 01/2023 - 06/2022
2	Oral Hygiene (Dental Hygiene) 04/2021 - 11/2018
2	Drug Therapy (Chemotherapy) 12/2020 - 05/2015
1	Art Therapy 03/2024
1	Long-Term Care 02/2024
1	Institutionalization (Institutionalized Persons) 12/2020
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Contraindications 12/2020
1	Length of Stay 12/2020
1	Duration of Therapy 01/2020
1	Prostheses and Implants (Prosthesis) 12/2014